Evidence map›Paper›PMID 20544827›Full record

ArticleJournal of neuroscience research2010

Corticotropin-releasing factor-2 activation prevents gentamicin-induced oxidative stress in cells derived from the inner ear.

Johnvesly Basappa, Sevin Turcan, Douglas E Vetter

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. CRF and urocortin 3 protect the heart from hypoxia/reoxygenation-induced apoptosis in zebrafish.American journal of physiology. Regulatory, integrative and comparative physiology · 2017
    Article
  4. Review
  5. Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.Journal of the Association for Research in Otolaryngology : JARO · 2014
    Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Johnvesly BasappaDepartment of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Sevin Turcan
Douglas E Vetter
Tufts University · US

Funding

Investigations into the mouse olivocochlear systemR01DC006258 · NIDCD · TUFTS UNIVERSITY BOSTON · PI VETTER, DOUGLAS E · 2004 to 2008
$1.9M
NIDCD NIH HHS R01 DC006258NIDCD NIH HHS R01DC006258
6 · The paper itself

Abstract

Generation of reactive oxygen species (ROS) is a common denominator in many conditions leading to cell death in the cochlea, yet little is known of the cochlea's endogenous mechanisms involved in preventing oxidative stress and its consequences in the cochlea. We have recently described a corticotropin-releasing factor (CRF) signaling system in the inner ear involved in susceptibility to noise-induced hearing loss. We use biochemical and proteomics assays to define further the role of CRF signaling in the response of cochlear cells to aminoglycoside exposure. We demonstrate that activity via the CRF(2) class of receptors protects against aminoglycoside-induced ROS production and activation of cell death pathways. This study suggests for the first time a role for CRF signaling in protecting the cochlea against oxidative stress, and our proteomics data suggest novel mechanisms beyond induction of free radical scavengers that are involved in its protective mechanisms.

Indexed as

AnimalsCaspase 3Cell DeathCell Line, TransformedCorticotropin-Releasing HormoneEar, InnerGas Chromatography-Mass SpectrometryGentamicinsNeuronsOxidative StressProtein Synthesis InhibitorsProteomeReactive Oxygen SpeciesSignal TransductionSuperoxide DismutaseCaspase 3Corticotropin-Releasing HormoneGentamicinsProtein Synthesis InhibitorsProteomeReactive Oxygen SpeciesSuperoxide Dismutase

Identifiers

PMID20544827
PMCPMC2947086
OpenAlexW1976781386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.